Table 3.
Age and sex groups | Hospitalizations prevented | Excess vaccine‐related myocarditis cases |
---|---|---|
All 18–39 years old | ||
mRNA‐1273 vaccine (Moderna®) | 2982 | 33 |
BNT162b2 mRNA (Pfizer‐BioNTech®) | 2820 | 24 |
Males 18–39 years old | ||
mRNA‐1273 vaccine (Moderna®) | 1903 | 68 |
BNT162b2 mRNA (Pfizer‐BioNTech®) | 1799 | 47 |